Bristol Myers Squibb Valued At $75 Per Share
- Tuesday, September 8, 2020, 7:10
- Market
- Add a comment
Bristol Myers Squibb’s stock (NYSE: BMY) gained almost 30% – increasing from $46 levels on March 23 when markets made a bottom, to around $60 now, underperforming the S&P500, which grew 54%. Why? Pharmaceutical companies, such as Bristol Myers Squibb are not immune to the current crisis…
About the Author
admin123 has written 23402 stories on this site.
